OraSure Technologies Welcomes Jack Kenny to Board Leadership

OraSure Technologies Strengthens Board with New Appointment

OraSure Technologies, Inc. (NASDAQ: OSUR), a pioneering company in diagnostic tests and sample management solutions, has taken a significant step forward by electing Jack Kenny to its Board of Directors. This strategic move adds valuable expertise to OraSure's leadership team, enhancing its ability to navigate the evolving healthcare landscape.

Expertise and Experience of Jack Kenny

Jack Kenny brings a wealth of knowledge to the board, having previously served as the Chief Executive Officer of Meridian Bioscience. During his tenure, he played a crucial role in revitalizing the company, ultimately leading to its acquisition. With over 30 years of experience in the diagnostics, molecular, and laboratory services industries, Mr. Kenny's insights will be invaluable as OraSure continues to innovate and expand its offerings.

Mr. Kenny will serve as a Class I Director until the company’s 2025 Annual Meeting of Stockholders, bolstering the Board’s breadth of experience with his diverse operational background. His prior roles include Senior Vice President and General Manager at Siemens Healthcare and Vice President and General Manager for Becton Dickinson’s Diagnostic Systems, where he further honed his strategic leadership skills.

Mara Aspinall's Perspective on the Appointment

Mara Aspinall, Chair of the Board of Directors at OraSure, expressed enthusiasm regarding Mr. Kenny’s appointment. "We recognize the significant value and industry expertise that Jack will contribute, and we are pleased to continue to strengthen our Board with his participation,” she stated. Aspinall cited the company's ongoing progress in strengthening its foundations and increasing profitability, emphasizing how Mr. Kenny's input will amplify these efforts.

Growth and Strategic Vision of OraSure Technologies

Under the guidance of President and CEO Carrie Eglinton Manner, OraSure Technologies has been on a path of continuous growth and improvement. The addition of Mr. Kenny is expected to further enhance the leadership team’s capabilities, allowing the company to better address increasing demands in the diagnostics market. OraSure Technologies is committed to improving the accessibility, quality, and overall value of healthcare through innovation and strategic foresight.

About OraSure Technologies

OraSure Technologies is continually transforming health through actionable insights and solutions that connect people with healthcare. The company focuses on developing and distributing rapid diagnostic tests and sample collection devices meant for the detection of critical health conditions. Together with its subsidiary, DNA Genotek Inc., OraSure is a trusted provider within the healthcare sector, supplying its products globally to a variety of sectors including clinical laboratories, hospitals, clinics, and public health organizations.

With a robust product portfolio encompassing diagnostic tests and collection devices, OraSure is dedicated to addressing the evolving needs of healthcare professionals and patients alike. The company’s innovative solutions are pivotal in discovering and detecting medical conditions, reinforcing its commitment to enhancing public health worldwide.

Contact Information for Investors and Media

For those interested in learning more about OraSure Technologies, the company provides dedicated contacts for investor relations and media inquiries:

Investor Contact:
Jason Plagman
Vice President, Investor Relations
investorinfo@orasure.com

Media Contact:
Amy Koch
Director, Corporate Communications
media@orasure.com

Frequently Asked Questions

What role will Jack Kenny play in OraSure Technologies?

Jack Kenny will serve as a Class I Director on the Board, offering his extensive expertise in the diagnostics industry.

How does OraSure Technologies contribute to healthcare?

OraSure Technologies develops innovative diagnostic tests and sample management solutions that improve healthcare accessibility and quality.

What experience does Jack Kenny have in the healthcare sector?

Jack Kenny has over 30 years of experience in the diagnostics and lab services industries, including leadership roles at Meridian Bioscience and Siemens Healthcare.

Who leads OraSure Technologies?

OraSure Technologies is led by President and CEO Carrie Eglinton Manner, along with a diverse and experienced Board of Directors.

What is the significance of the new appointment?

Jack Kenny's appointment to the Board aims to enhance strategic decision-making and drive growth for OraSure Technologies as it navigates a competitive market.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.